Company profile: Inform Diagnostics
1.1 - Company Overview
Company description
- Provider of anatomic pathology and quality assurance services, offering subspecialty diagnostics in gastrointestinal, dermatopathology, urologic, hematopathology, and breast pathology. Services include GI diagnostics for Crohn’s disease and hepatitis, detailed prostate biopsy reports, molecular/antibody-based and genetic testing, and ancillary and in-house testing.
Products and services
- Hematopathology: Conducts molecular and antibody-based diagnostics and genetic testing for blood-related conditions in hematopathology practice, molecular diagnostics–enabled
- Subspecialty Anatomic Pathology Services: Delivers specialized anatomic pathology across gastrointestinal, dermatopathology, urologic, hematopathology, and breast disciplines to support accurate disease diagnosis and interpretation, subspecialty
- Urologic Pathology: Produces detailed prostate biopsy reports and advanced in-house testing for urologic conditions across urologic pathology cases, in-house
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Inform Diagnostics
ADL Health
HQ: United States
Website
- Description: Provider of PCR-focused laboratory testing services, based in Texas and certified under the Clinical Laboratory Improvement Amendments (CLIA).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADL Health company profile →
MMDS Mobile X-Ray
HQ: United States
Website
- Description: Provider of mobile diagnostic imaging and ancillary healthcare services delivered directly to patients across healthcare and correctional facilities. Offerings include mobile x-rays, vascular access, sleep studies, and Holter monitoring to increase accessibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MMDS Mobile X-Ray company profile →
Delaware Clinical & Laboratory Physicians
HQ: United States
Website
- Description: Provider of hematology and pathology medicine services, exposed to the latest technology and automation in laboratory medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Delaware Clinical & Laboratory Physicians company profile →
Hexarad
HQ: United Kingdom
Website
- Description: Provider of tech-enabled teleradiology supporting remote reporting of medical scans such as CTs, MRIs and X-rays. Offers the Hexarad Platform for radiology solutions with fast and accurate diagnosis through remote reporting; ReportRad for access to subspecialist radiologists for routine, urgent and out-of-hours reporting; OptiRad workflow management software; and the Hexarad Thought Leadership Institute.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hexarad company profile →
HealthTrackRx
HQ: United States
Website
- Description: Provider of advanced molecular diagnostic and clinical solutions, including PCR testing for viral, bacterial, and fungal infections with next-morning results; antimicrobial resistance solutions and personalized antibiograms; syndromic testing menus (urinary, gastrointestinal, STD/STI, respiratory); toxicology screening and pain management services; a universal collection device; and a financial assistance program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthTrackRx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Inform Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inform Diagnostics
2.2 - Growth funds investing in similar companies to Inform Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Inform Diagnostics
4.2 - Public trading comparable groups for Inform Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →